HLA-B molecules target more conserved regions of the HIV-1 proteome

被引:16
|
作者
Costa, Ana I. Fontaine [2 ]
Rao, Xiangyu [1 ]
LeChenadec, Emmanuelle [1 ]
van Baarle, Debbie [2 ,4 ]
Kesmir, Can [1 ,3 ]
机构
[1] Univ Utrecht, Dept Theoret Biol Bioinformat, NL-3584 CH Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Immunol, Wilhelmina Childrens Hosp, Utrecht, Netherlands
[3] Univ Utrecht, Acad Biomed Ctr, NL-3584 CH Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Heidelberglaan, Netherlands
关键词
conservation; CTL epitopes; database; entropy; genome-wide analysis; HLA; immunodominance; HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; VIRAL LOAD; CLASS-I; LYMPHOCYTE EPITOPES; ESCAPE MUTATIONS; TYPE-1; ALLELES; INFECTION; PROTEINS;
D O I
10.1097/QAD.0b013e328334442e
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: HLA-B alleles of HIV-infected individuals have been shown to have a major impact on their rate of progression toward AIDS, and the T-cell responses they restrict are immunodominant. Objective: We sought to identify whether the association of HLA-B alleles with rate of progression toward AIDS is due to targeting of more restricted and thus more conserved regions of the HIV-1 proteome. Methods: Each residue of the HIV-1 consensus subtype B sequence was coded according to the presence/absence of an epitope, using the compiled epitope data available in the HIV-LANL immunology database. The Shannon entropy for each HXB2 position was calculated using pre-aligned HIV-1 clade B sequences as a measure of its degree of conservation. We then compared the entropy of empty versus epitope-containing positions and HLA-B-restricted versus HLA-A-restricted positions. Results: Positions containing CD8(+) epitopes were significantly more conserved than corresponding empty positions. Moreover, residues targeted by HLA-B alleles in the HIV-1 proteome were significantly more conserved than the ones targeted by HLA-A alleles. Analysing a recent dataset, we found that B epitope regions contain significantly more escape mutations and reversions, which might be the reason why we find them to be more conserved. Conclusion: Our results suggest that epitopes in HIV-1 targeted by HLA-B alleles lie in more constrained regions of its proteins, in which mutations might have a higher fitness cost and tend to revert. Consequently, HLA-B-restricted cytotoxic T-lymphocyte (CTL) responses may persist longer. This may be one of the factors contributing to the immunodominance and impact of HLA-B-restricted CTL responses on disease progression. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:211 / 215
页数:5
相关论文
共 50 条
  • [1] AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz
    de Groot, Natasja G.
    Heijmans, Corrine M. C.
    Zoet, Yvonne M.
    de Ru, Arnoud H.
    Verreck, Frank A.
    van Veelen, Peter A.
    Drijfhout, Jan W.
    Doxiadis, Gaby G. M.
    Remarque, Edmond J.
    Doxiadis, Ilias I. N.
    van Rood, Jon J.
    Koning, Frits
    Bontrop, Ronald E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (34) : 15175 - 15180
  • [2] A SYSTEMATIC REVIEW ON THE INFLUENCE OF HLA-B POLYMORPHISMS ON HIV-1 MOTHER-TO-CHILD-TRANSMISSION
    Cubillos Angulo, Juan Manuel
    Castro Cuesta, Taryn Ariadna
    Menezes, Eliane Pereira
    Pedroso, Celia
    Brites, Carlos
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2019, 23 (01) : 53 - 59
  • [3] Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients
    Crawford, Hayley
    Lumm, Wendy
    Leslie, Alasdair
    Schaefer, Malinda
    Boeras, Debrah
    Prado, Julia G.
    Tang, Jianming
    Farmer, Paul
    Ndung'u, Thumbi
    Lakhi, Shabir
    Gilmour, Jill
    Goepfert, Paul
    Walker, Bruce D.
    Kaslow, Richard
    Mulenga, Joseph
    Allen, Susan
    Goulder, Philip J. R.
    Hunter, Eric
    JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (04) : 909 - 921
  • [4] HLA-B☆57 versus HLA-B☆81 in HIV-1 Infection: Slow and Steady Wins the Race?
    Prentice, Heather A.
    Porter, Travis R.
    Price, Matthew A.
    Cormier, Emmanuel
    He, Dongning
    Farmer, Paul K.
    Kamali, Anatoli
    Karita, Etienne
    Lakhi, Shabir
    Sanders, Eduard J.
    Anzala, Omu
    Amornkul, Pauli N.
    Allen, Susan
    Hunter, Eric
    Kaslow, Richard A.
    Gilmour, Jill
    Tang, Jianming
    JOURNAL OF VIROLOGY, 2013, 87 (07) : 4043 - 4051
  • [5] Relative Resistance of HLA-B to Downregulation by Naturally Occurring HIV-1 Nef Sequences
    Mahiti, Macdonald
    Toyoda, Mako
    Jia, Xiaofei
    Kuang, Xiaomei T.
    Mwimanzi, Francis
    Mwimanzi, Philip
    Walker, Bruce D.
    Xiong, Yong
    Brumme, Zabrina L.
    Brockman, Mark A.
    Ueno, Takamasa
    MBIO, 2016, 7 (01):
  • [6] Evolution of HLA-B*5703 HIV-1 escape mutations and their impact on HIV-1 replicative capacity
    Crawford, H.
    Lumm, W.
    Leslie, A.
    Schaefer, M.
    Boeras, D.
    Prado, J.
    Mulenga, J.
    Allen, S.
    Goulder, P.
    Hunter, E.
    RETROVIROLOGY, 2009, 6
  • [7] Evolution of the HIV-1 nef gene in HLA-B*57 Positive Elite Suppressors
    Salgado, Maria
    Brennan, Timothy P.
    O'Connell, Karen A.
    Bailey, Justin R.
    Ray, Stuart C.
    Siliciano, Robert F.
    Blankson, Joel N.
    RETROVIROLOGY, 2010, 7
  • [8] HIV-1 Evolution Following Transmission to an HLA-B☆5801-Positive Patient
    O'Connell, Karen A.
    Xu, Jie
    Durbin, Anna P.
    Apuzzo, Linda G.
    Imteyaz, Hejab
    Williams, Thomas M.
    Ray, Stuart C.
    Margolick, Joseph B.
    Siliciano, Robert F.
    Blankson, Joel N.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (12) : 1820 - 1824
  • [9] Crystal structure of HLA-B*5801, a protective HLA allele for HIV-1 infection
    Li, Xiaolong
    Lamothe, Pedro A.
    Ng, Robert
    Xu, Shutong
    Teng, Maikun
    Walker, Bruce D.
    Wang, Jia-huai
    PROTEIN & CELL, 2016, 7 (10) : 761 - 765
  • [10] Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects
    Roff, Shannon R.
    Sanou, Missa P.
    Rathore, Mobeen H.
    Levy, Jay A.
    Yamamoto, Janet K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) : 1540 - 1556